Baxter International slashed its 2025 profit forecast and posted disappointing quarterly earnings on Thursday, as lingering ...

We came across a bullish thesis on Baxter International Inc. on DeepValue Capital’s Substack. In this article, we will ...

Valued at a market cap of $11.3 billion, Baxter International Inc. (BAX) is a global healthcare and medtech company ...

Stocks in a Bloodbath. Baxter International Inc. (NYSE:BAX) is one of the worst-performing stocks on Thursday. Baxter ...

Stifel downgraded Baxter International to ‘Hold’ from ‘Buy’ and slashed the price target to $25 from $36. The analysts ...

Deerfield-based Baxter International is still feeling battered by Hurricane Helene and problems with its Novum infusion pumps ...

Baxter International (NYSE:BAX) stock drops after the company's Q2 results miss consensus and Q3 projection fails to meet ...

Detailed price information for Baxter International Inc (BAX-N) from The Globe and Mail including charting and trades.

Shares of Baxter International Inc. BAX rose 2.22% to $23.98 Tuesday, on what proved to be an all-around great trading ...

Baxter International Inc. closed 30.72% below its 52-week high of $40.49, which the company achieved on September 17th.

Baxter International Inc. (NYSE: BAX) Q3 2023 Earnings Conference Call November 2, 2023 8:30 AM ET Company Participants Joe Almeida - Chairman, Chief Executive Officer Joel Grade - Executive Vice ...

Baxter International BAX 1.10% is selling its kidney care segment to Carlyle CG 2.06% Group for $3.8 billion, most of which will be paid in cash. The Deerfield, Ill., medical-device maker on ...